company background image
FBRX logo

Forte Biosciences NasdaqCM:FBRX Stock Report

Last Price

US$16.68

Market Cap

US$23.5m

7D

181.5%

1Y

44.2%

Updated

26 Nov, 2024

Data

Company Financials +

Forte Biosciences, Inc.

NasdaqCM:FBRX Stock Report

Market Cap: US$23.5m

Forte Biosciences, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Forte Biosciences
Historical stock prices
Current Share PriceUS$16.68
52 Week HighUS$21.25
52 Week LowUS$4.11
Beta1.46
11 Month Change256.52%
3 Month Change115.78%
1 Year Change44.23%
33 Year Change-74.92%
5 Year Changen/a
Change since IPO-96.03%

Recent News & Updates

Recent updates

We're A Little Worried About Forte Biosciences' (NASDAQ:FBRX) Cash Burn Rate

Jul 17
We're A Little Worried About Forte Biosciences' (NASDAQ:FBRX) Cash Burn Rate

Is Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans?

Mar 14
Is Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans?

Large Forte Biosciences shareholder scolds company board of directors

Aug 24

We're Hopeful That Forte Biosciences (NASDAQ:FBRX) Will Use Its Cash Wisely

Aug 17
We're Hopeful That Forte Biosciences (NASDAQ:FBRX) Will Use Its Cash Wisely

Forte Biosciences: Lots Of Clinical Risk Ahead And A Questionable Business Plan

Aug 16

Forte Biosciences large shareholders make demands for company's future

Jul 07

We Think Forte Biosciences (NASDAQ:FBRX) Needs To Drive Business Growth Carefully

Dec 23
We Think Forte Biosciences (NASDAQ:FBRX) Needs To Drive Business Growth Carefully

Forte Biosciences files for $300M mixed shelf offering

May 28

Are Insiders Buying Forte Biosciences, Inc. (NASDAQ:FBRX) Stock?

Mar 13
Are Insiders Buying Forte Biosciences, Inc. (NASDAQ:FBRX) Stock?

Do Institutions Own Forte Biosciences, Inc. (NASDAQ:FBRX) Shares?

Jan 19
Do Institutions Own Forte Biosciences, Inc. (NASDAQ:FBRX) Shares?

Forte Biosciences: FB-401 Potentially Best-In-Class In Atopic Dermatitis

Dec 18

Who Has Been Buying Forte Biosciences, Inc. (NASDAQ:FBRX) Shares?

Nov 25
Who Has Been Buying Forte Biosciences, Inc. (NASDAQ:FBRX) Shares?

Forte Biosciences readies equity offering

Oct 28

Shareholder Returns

FBRXUS BiotechsUS Market
7D181.5%4.0%2.0%
1Y44.2%18.0%32.4%

Return vs Industry: FBRX exceeded the US Biotechs industry which returned 18.3% over the past year.

Return vs Market: FBRX exceeded the US Market which returned 32.6% over the past year.

Price Volatility

Is FBRX's price volatile compared to industry and market?
FBRX volatility
FBRX Average Weekly Movement37.1%
Biotechs Industry Average Movement9.8%
Market Average Movement6.3%
10% most volatile stocks in US Market15.9%
10% least volatile stocks in US Market3.1%

Stable Share Price: FBRX's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: FBRX's weekly volatility has increased from 22% to 37% over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a11Paul A. Wagnerwww.fortebiorx.com

Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Forte Biosciences, Inc. Fundamentals Summary

How do Forte Biosciences's earnings and revenue compare to its market cap?
FBRX fundamental statistics
Market capUS$23.48m
Earnings (TTM)-US$34.19m
Revenue (TTM)n/a

0.0x

P/S Ratio

-0.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
FBRX income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$34.20m
Earnings-US$34.19m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-23.42
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did FBRX perform over the long term?

See historical performance and comparison